Insight

Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski

Photo of Robert Z. Orlowski from faculty.mdanderson.org

May 4, 2024, 15:56

Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski

Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X:

“Myeloma Paper of the Day: Minimal residual disease status in multiple myeloma 1 year after autologous hematopoietic cell transplantation and lenalidomide maintenance are associated with long-term overall survival.”

Authors: Marcelo Pasquini, Paul Wallace, Brent Logan, Manmeet Kaur, Joseph Tario Jr, Alan Howard, Yali Zhang, Claudio Brunstein, Yvonne Efebera, Nancy Geller, Sergio Giralt, Parameswaran Hari, Mary M. Horowitz, John Koreth, Amrita Krishnan, Heather Landau, George Somlo, Nina Shah, Edward Stadtmauer, Dan Vogl, and Theresa Hahn.

Myeloma Paper of the Day

Source: Robert Orlowski/X

Alan Howard Amrita Krishnan Brent Logan cancer Claudio Brunstein Dan Vogl Edward Stadtmauer George Somlo Heather Landau John Koreth Joseph Tario Jr Manmeet Kaur Marcelo Pasquini Mary M. Horowitz MD Anderson Cancer Center MRD in multiple myeloma multiple myeloma Myeloma Paper of the Day Nancy Geller Nina Shah OncoDaily Oncology Parameswaran Hari Paul Wallace Robert Orlowski Sergio Giralt Theresa Hahn Yali Zhang Yvonne Efebera

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage